Literature DB >> 27590431

Evaluation of vaccination safety in children with mastocytosis.

Roberta Parente1, Valentina Pucino2,3, Diomira Magliacane1, Angelica Petraroli2, Stefania Loffredo2, Giancarlo Marone4, Massimo Triggiani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27590431     DOI： 10.1111/pai.12647

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  13 in total

1.  Predicting behavioral intentions to children vaccination among Chinese parents: an extended TPB model.

Authors:  Min Zhou; Lindu Zhao; Nan Kong; Kathryn S Campy; Song Wang; Shujuan Qu
Journal:  Hum Vaccin Immunother       Date:  2018-09-21       Impact factor: 3.452

2.  COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.

Authors:  Tiago Azenha Rama; Joana Miranda; Diana Silva; Luís Amaral; Eunice Castro; Alice Coimbra; André Moreira; José Luís Plácido
Journal:  Vaccines (Basel)       Date:  2022-05-04

Review 3.  Pediatric Mastocytosis: Recognition and Management.

Authors:  Julie V Schaffer
Journal:  Am J Clin Dermatol       Date:  2021-03       Impact factor: 7.403

Review 4.  Mast Cell Activation Disorders.

Authors:  Arianna Giannetti; Emanuele Filice; Carlo Caffarelli; Giampaolo Ricci; Andrea Pession
Journal:  Medicina (Kaunas)       Date:  2021-01-30       Impact factor: 2.430

Review 5.  Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.

Authors:  Knut Brockow; Katarzyna Plata-Nazar; Magdalena Lange; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

Review 6. 

Authors:  Ludger Klimek; Karl-Christian Bergmann; Randolf Brehler; Wolfgang Pfützner; Margitta Worm; Karin Hartmann; Thilo Jakob; Natalija Novak; Johannes Ring; Eckard Hamelmann; Tobias Ankermann; Sebastian M Schmidt; Eva Untersmayr; Wolfram Hötzenecker; Erika Jensen-Jarolim; Torsten Zuberbier
Journal:  Allergo J       Date:  2021-05-07

Review 7.  COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM).

Authors:  Patrizia Bonadonna; Knut Brockow; Marek Niedoszytko; Hanneke Oude Elberink; Cem Akin; Boguslaw Nedoszytko; Joseph H Butterfield; Ivan Alvarez-Twose; Karl Sotlar; Juliana Schwaab; Mohamad Jawhar; Mariana Castells; Wolfgang R Sperr; Olivier Hermine; Jason Gotlib; Roberta Zanotti; Andreas Reiter; Sigurd Broesby-Olsen; Carsten Bindslev-Jensen; Lawrence B Schwartz; Hans-Peter Horny; Deepti Radia; Massimo Triggiani; Vito Sabato; Melody C Carter; Frank Siebenhaar; Alberto Orfao; Clive Grattan; Dean D Metcalfe; Michel Arock; Theo Gulen; Karin Hartmann; Peter Valent
Journal:  J Allergy Clin Immunol Pract       Date:  2021-04-05

8.  Safety of COVID-19 Vaccination in Patients with Mastocytosis and Monoclonal Mast Cell Activation Syndrome.

Authors:  Rayan Kaakati; Dilawar Khokhar; Cem Akin
Journal:  J Allergy Clin Immunol Pract       Date:  2021-05-22

9.  Mast Cells: Fascinating but Still Elusive after 140 Years from Their Discovery.

Authors:  Gilda Varricchi; Gianni Marone
Journal:  Int J Mol Sci       Date:  2020-01-11       Impact factor: 5.923

Review 10.  Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.

Authors:  Magdalena Lange; Karin Hartmann; Melody C Carter; Frank Siebenhaar; Ivan Alvarez-Twose; Inés Torrado; Knut Brockow; Joanna Renke; Ninela Irga-Jaworska; Katarzyna Plata-Nazar; Hanna Ługowska-Umer; Justyna Czarny; Anna Belloni Fortina; Francesca Caroppo; Roman J Nowicki; Bogusław Nedoszytko; Marek Niedoszytko; Peter Valent
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.